Cart
0
Get 20% Free Customization In This Report
Buy this report from - $3456

Animal Therapeutics and Diagnostics Market by Therapeutic Products (Anti-Parasitic Drugs and Antibiotics, Anti-inflammatory Drugs, Anesthetics, and Other Drugs), Diagnostics Products (Instruments and Consumables), Animal Type (Companion Animals, Cattle, Pigs, Poultry, and Sheep) - Global Opportunity Analysis and Industry Forecast, 2014-2022

LI_171949
Pages: 114
Feb 2017 | 1806 Views
face gplus_n
Author's : Onkar Sumant
Tables: 51
Charts: 49
twit_n pr_n

Animal Therapeutics And Diagnostics Market Overview

Global animal therapeutics and diagnostics market was valued at $23,793 million in 2015, and is projected to reach $36,226 million by 2022, growing at a CAGR of 6.1% from 2016 to 2022. Diagnostic instruments aid in the determination of causative agents of diseases. Animal diagnostics incorporate a variety of instruments and consumables to diagnose the ailment, which is very essential considering public dependency on animals. Animals serve as an important source of food, meat, milk, protein, and many other commercial products such as leather. This makes animal health endurable. Animal therapeutics aid in treatment of the ailments involving use of drugs, which cure the disease based on their mode of action. Veterinary diagnostic instruments include ophthalmoscopy, laryngoscopes, ENT equipment, and other instruments such as PCR analyzers. Animal therapeutic products include various drugs such as tranquilizers, sedatives, painkillers, and antibiotics. Constant development in animal therapeutics and diagnostic instruments is necessary with continuous emergence of different diseases.

Animal Therapeutics and Diagnostics Market

Get more information on this report : Request Sample Pages

The report analyzes the animal therapeutics and diagnostics market into three segments-product type, animal type, and geography. By product type, the market is bifurcated into animal therapeutic products and animal diagnostics products. Animal therapeutic products is further segmented anti-parasitic drugs and antibiotics, anti-inflammatory drugs, anesthetics, and other drugs. On the other hand, animal diagnostic products can be classified as instruments and consumables. Based on animal type, the animal therapeutics and diagnostics market is mainly categorized into five segments: companion animals, cattle, pigs, poultry, and sheep. Companion animals is further divided into dogs, cats, and others. Based on geography, the protein labeling market is categorized into North America, Europe, Asia-Pacific, and LAMEA.

The animal therapeutics and diagnostics market is growing at a steady pace due to the increase in pet ownership worldwide, especially in the developing countries. This has led to the innovation of diagnostic instruments and emergence of novel therapeutic drugs for animals. For instance, in August 2015, Bayer Animal Health launched Zelnate, used for the treatment of bovine respiratory diseases. Moreover, growth in the investment for development of advanced products is also expected to fuel the market growth. For example, in July 2016, Merck acquired 93% of Vallée S.A. for $400 million to strengthen its presence in Latin America.

The key players profiled in this report include Bayer AG, Eli Lilly and Company, Boehringer, Ingelheim GmbH, Merck & Co., Inc., Zoetis Inc., Ceva Santé Animale, Sanofi S.A., Nutreco N.V., and Virbac S.A.

The other players in the animal therapeutics and diagnostics market include Abaxis Inc., Heska Corp., IDEXX Laboratories Inc., Novartis Animal Health Inc., and Pfizer Animal Health.

Asia-Pacific possesses high market potential for growth of animal therapeutics and diagnostics due to increase in pet ownership and rise emergence of various zoonotic diseases. Progress in the research on therapeutic drugs and diagnostic instruments has led to rapid developments in the animal therapeutics and diagnostics. Increase in investments done by large scale pharmaceutical companies in animal health care companies has improved the production of innovative drugs and diagnostic instruments.

Saudi Arabia animal therapeutics and diagnostics market is projected to grow at a high CAGR of 8.2% during the forecast period. In addition, Europe holds maximum share in the patent registration for both animal diagnostics and animal therapeutics, while Asia-Pacific experiences fast paced growth in terms of animal diagnostics and animal therapeutics.

Key Benefits for Stakeholders

  • The report provides an extensive analysis of the current trends and highlights the market potential from 2014 to 2022, in terms of value.
  • The market scenario is comprehensively analyzed with respect to the product and animal type.
  • Comprehensive analysis of the patents is provided to determine the prevailing opportunities.
  • Recent developments, key manufacturers, and market shares are listed in this report to analyze the competitive scenario of the market.
  • In-depth analysis of the market based on geography gives an understanding of the regional market, which assists in strategic business planning.

Animal Therapeutics and Diagnostics Market Key Segments

The global animal therapeutics and diagnostics market segmentation is explained below:

By Product

  • Animal Diagnostics Products
  • Instruments
  • Consumables
  • Animal Therapeutics Products
  • Anti-Parasitic Drugs and Antibiotics
  • Anti-Inflammatory Drugs
  • Anesthetics
  • Other Drugs

By Animal type

  • Companion Animals
  • Dogs
  • Cats
  • Other Companion Animals
  • Cattle
  • Pigs
  • Poultry
  • Sheep

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Taiwan
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Turkey
    • Venezuela
    • Saudi Arabia
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. Key Benefits
1.3. Key Market Segments
1.4. Research Methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO Perspective

Chapter: 3 MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets

3.3. Government regulations

3.3.1. Center for Veterinary Medicine (CVM)
3.3.2. Environmental Protection Agency (EPA)

3.4. Patents Analysis

3.4.1. PATENT ANALYSIS BY YEAR

3.4.1.1. Patent analysis of animal therapeutics by year
3.4.1.2. Patent analysis of animal diagnostics by year

3.4.2. PATENT ANALYSIS BY REGION

3.4.2.1. Patent analysis of animal diagnostics by region
3.4.2.2. Patent analysis of animal diagnostics by region

3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Rising demand for animal derived food products
3.5.1.2. Growing demand for pet insurance
3.5.1.3. Rising concern to prevent zoonotic diseases
3.5.1.4. Growing ownership of companion animals
3.5.1.5. Rising animal health expenditure

3.5.2. Restraints

3.5.2.1. Highly competitive meat and milk prices
3.5.2.2. Lack of animal health awareness
3.5.2.3. Adverse impact of veterinary drugs on human and animal health

3.5.3. Opportunities

3.5.3.1. Advancement in therapeutic and diagnostic products
3.5.3.2. Therapeutic and diagnostic products for hybrid animals

Chapter: 4 ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. animal diagnostics products

4.2.1. Market size and forecast
4.2.2. Instruments

4.2.2.1. Key market trends
4.2.2.2. Key growth factors and opportunities

4.2.3. Consumables

4.2.3.1. Key market trends
4.2.3.2. Key growth factors and opportunities

4.3. animal therapeutics products

4.3.1. Market size and forecast
4.3.2. Anti-Parasitic drugs and antibiotics

4.3.2.1. Key market trends
4.3.2.2. Key growth factors and opportunities

4.3.3. Anti-Inflammatory drugs

4.3.3.1. Key market trends
4.3.3.2. Key growth factors and opportunities

4.3.4. Anesthetics

4.3.4.1. Key market trends
4.3.4.2. Key growth factors and opportunities

4.3.5. Others

4.3.5.1. Key market trends
4.3.5.2. Key growth factors and opportunities

Chapter: 5 ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE

5.1. Overview

5.1.1. Market size and forecast

5.2. Companion Animals

5.2.1. Market size and forecast
5.2.2. Dogs
5.2.3. Cats
5.2.4. Other Companion Animals

5.3. Cattle

5.3.1. Market size and forecast

5.4. Pigs

5.4.1. Market size and forecast

5.5. Poultry

5.5.1. Market size and forecast

5.6. Sheep

5.6.1. Market size and forecast

Chapter: 6 ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY GEOGRAPHY

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S. market size & forecast
6.2.5. Canada market size and forecast
6.2.6. Mexico market size and forecast

6.3. Europe

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. Germany market size and forecast
6.3.5. France market size and forecast
6.3.6. UK market size and forecast
6.3.7. Italy market size and forecast
6.3.8. Rest of Europe market size and forecast

6.4. Asia-Pacific

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan market size and forecast
6.4.5. China market size and forecast
6.4.6. Australia market size and forecast
6.4.7. India market size and forecast
6.4.8. South Korea market size and forecast
6.4.9. Taiwan market size and forecast
6.4.10. Rest of Asia-Pacific market size and forecast

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil market size and forecast
6.5.5. Turkey market size and forecast
6.5.6. Venezuela market size and forecast
6.5.7. Saudi Arabia market size and forecast
6.5.8. Rest of LAMEA market size and forecast

Chapter: 7 COMPANY PROFILES

7.1. Bayer AG

7.1.1. Company overview
7.1.2. Operating business segments
7.1.3. Business performance
7.1.4. Key strategic moves & developments

7.2. Eli Lilly and Company

7.2.1. Company overview
7.2.2. Operating business segments
7.2.3. Business performance
7.2.4. Key strategic moves & developments

7.3. Boehringer, Ingelheim GmbH

7.3.1. Company overview
7.3.2. Operating business segments
7.3.3. Business performance

7.4. Merck & Co.

7.4.1. Company overview
7.4.2. Business performance
7.4.3. Key strategic moves & developments

7.5. Zoetis Inc.

7.5.1. Company overview
7.5.2. Operating business segments
7.5.3. Business performance

7.6. Ceva Santé Animale

7.6.1. Company overview
7.6.2. Operating business segments
7.6.3. Business performance

7.7. Sanofi S.A.

7.7.1. Company overview
7.7.2. Operating business segments
7.7.3. Business performance
7.7.4. Key strategic moves & developments

7.8. Nutreco N.V.

7.8.1. Company overview
7.8.2. Operating business segments
7.8.3. Business performance

7.9. Virbac S.A.

7.9.1. Company overview
7.9.2. Business performance
7.9.3. Key strategic moves & development

*Details on financial performance, strategic moves and developments may not be captured for unlisted companies.
*Please note this is a tentative TOC and may change with research proceedings.

LIST OF TABLES

TABLE 1. GLOBAL ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT ($ MILLION)
TABLE 2. GLOBAL ANIMAL DIAGNOSTICS MARKET, BY TYPE ($ MILLION)
TABLE 3. GLOBAL ANIMAL THERAPEUTICS MARKET, BY TYPE ($ MILLION)
TABLE 4. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)
TABLE 5. GLOBAL COMPANION ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY GEOGRAPHY ($ MILLION)
TABLE 6. ANIMAL THERAPEUTICS AND DIAGNOSTICS CATTLE MARKET, BY GEOGRAPHY ($ MILLION)
TABLE 7. ANIMAL THERAPEUTICS AND DIAGNOSTICS PIGS MARKET, BY GEOGRAPHY ($ MILLION)
TABLE 8. ANIMAL THERAPEUTICS AND DIAGNOSTICS POULTRY MARKET, BY GEOGRAPHY ($ MILLION)
TABLE 9. ANIMAL THERAPEUTICS AND DIAGNOSTICS SHEEP MARKET, BY GEOGRAPHY ($ MILLION)
TABLE 10. NORTH AMERICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT ($ MILLION)
TABLE 11. NORTH AMERICA ANIMAL DIAGNOSTICS MARKET, BY TYPE ($ MILLION)
TABLE 12. NORTH AMERICA ANIMAL THERAPEUTICS MARKET, BY TYPE ($ MILLION)
TABLE 13. NORTH AMERICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)
TABLE 14. NORTH AMERICA COMPANION ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)
TABLE 15. NORTH AMERICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY ($ MILLION)
TABLE 16. EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT ($ MILLION)
TABLE 17. EUROPE ANIMAL DIAGNOSTICS MARKET, BY TYPE ($ MILLION)
TABLE 18. EUROPE ANIMAL THERAPEUTICS MARKET, BY TYPE ($ MILLION)
TABLE 19. EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)
TABLE 20. EUROPE COMPANION ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)
TABLE 21. EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY ($ MILLION)
TABLE 22. ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT ($ MILLION)
TABLE 23. ASIA-PACIFIC ANIMAL DIAGNOSTICS MARKET, BY TYPE ($ MILLION)
TABLE 24. ASIA-PACIFIC ANIMAL THERAPEUTICS MARKET, BY TYPE ($ MILLION)
TABLE 25. ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)
TABLE 26. ASIA-PACIFIC COMPANION ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)
TABLE 27. ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY ($ MILLION)
TABLE 28. LAMEA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT ($ MILLION)
TABLE 29. LAMEA ANIMAL DIAGNOSTICS MARKET, BY TYPE ($ MILLION)
TABLE 30. LAMEA ANIMAL THERAPEUTICS MARKET, BY TYPE ($ MILLION)
TABLE 31. LAMEA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)
TABLE 32. LAMEA COMPANION ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)
TABLE 33. LAMEA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY ($ MILLION)
TABLE 34. BAYER: COMPANY SNAPSHOT
TABLE 35. BAYER: OPERATING SEGMENTS
TABLE 36. ELI LILLY: COMPANY SNAPSHOT
TABLE 37. ELI LILLY: OPERATING SEGMENTS
TABLE 38. BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
TABLE 39. BOEHRINGER INGELHEIM: OPERATING SEGMENTS
TABLE 40. MERCK: COMPANY SNAPSHOT
TABLE 41. MERCK: OPERATING SEGMENTS
TABLE 42. ZOETIS: COMPANY SNAPSHOT
TABLE 43. ZOETIS: OPERATING SEGMENTS
TABLE 44. CEVA SANTÉ ANIMALE: COMPANY SNAPSHOT
TABLE 45. CEVA SANTÉ ANIMALE: OPERATING SEGMENTS
TABLE 46. SANOFI: COMPANY SNAPSHOT
TABLE 47. SANOFI: OPERATING SEGMENTS
TABLE 48. NUTRECO: COMPANY SNAPSHOT
TABLE 49. NUTRECO: OPERATING SEGMENTS
TABLE 50. VIRBAC: COMPANY SNAPSHOT
TABLE 51. VIRBAC: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. GLOBAL PATIENT MECHANICAL LIFT HANDLING EQUIPMENT MARKET: SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS: GLOBAL ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE
FIGURE 3. U.S. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 4. CANADA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 5. MEXICO ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 6. GERMANY ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 7. FRANCE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 8. UK ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 9. ITALY ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 10. REST OF EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 11. JAPAN ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 12. CHINA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 13. AUSTRALIA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 14. INDIA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 15. SOUTH KOREA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 16. TAIWAN ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 17. REST OF ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 18. BRAZIL ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 19. TURKEY ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 20. VENEZUELA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 21. SAUDI ARABIA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 22. REST OF LAMEA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022
FIGURE 23. BAYER: REVENUE, BY YEAR ($MILLION)
FIGURE 24. BAYER: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 25. BAYER: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 26. ELI LILLY: REVENUE, BY YEAR ($MILLION)
FIGURE 27. ELI LILLY: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 28. ELI LILLY: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 29. BOEHRINGER INGELHEIM: REVENUE, BY YEAR ($MILLION)
FIGURE 30. BOEHRINGER INGELHEIM: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 31. BOEHRINGER INGELHEIM: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 32. MERCK: REVENUE, BY YEAR ($MILLION)
FIGURE 33. MERCK: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 34. MERCK: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 35. ZOETIS: REVENUE, BY YEAR ($MILLION)
FIGURE 36. ZOETIS: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 37. ZOETIS: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 38. CEVA SANTÉ ANIMALE: REVENUE, BY YEAR ($MILLION)
FIGURE 39. CEVA SANTÉ ANIMALE: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 40. CEVA SANTÉ ANIMALE: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 41. SANOFI: REVENUE, BY YEAR ($MILLION)
FIGURE 42. SANOFI: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 43. SANOFI: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 44. NUTRECO: REVENUE, BY YEAR ($MILLION)
FIGURE 45. NUTRECO: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 46. NUTRECO: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 47. VIRBAC: REVENUE, BY YEAR ($MILLION)
FIGURE 48. VIRBAC: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 49. VIRBAC: REVENUE, BY GEOGRAPHY, 2015 (%)

 

The utilization of animal therapeutics drugs and diagnostic devices is expected to witness a moderate growth with increase in cases of varied animal diseases such as rabies, Newcastle disease, and diseases caused by rotavirus and parvovirus. The interest of healthcare industry increased in the animal therapeutics and diagnostics market owing to the need for animal derived food products such as meat & milk and the need of companion animal for safety of humans and companionship. The point of care diagnostics and the use of anti-parasitic drugs & antibiotics have widely increased. It has been observed that developed countries spend more on pets due to the higher buying power and consume more animal-based food, rather than plant-based foods, as compared to the developing and underdeveloped countries.

The rearing and domestication of animals has led to the development of hybrid animals due to their various advantages such as high yield, aesthetics, and sports. A lot of similar interbred varieties require proper regular medical attention and are more vulnerable to pathogens. This is estimated to further drive the animal therapeutics and diagnostics market. Many key players work toward developing products that are safe for the animals, humans, and the surrounding environment. Also, these products are more effective and efficient at killing the pest.  

The employment of technologically advanced animal therapeutic drugs and diagnostic devices is highest in North America, owing to increase in adoption of these products and presence of disposable income among the owners. The rise in the disposable income, demand for meat in the developing countries such as China and India, and increase in adoption of companion animals largely contribute toward the market growth. Strong bond between the owners and their companion animals and growing awareness among the owners about these products fuels the market growth. Another key animal type that largely contributes towards the market growth, owing to the rise in the demand of animal products, is cattle.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry

Request sample

OR

Purchase Full Report of
Animal Therapeutics and Diagnostics Market- Global Opportunity Analysis and Industry Forecast, 2014-2022

  • Online Only
  • $3456
  • Online cloud Access only
  • Restected Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370
  • Restricted to one authorized users
  • One print only
  • Available in PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $8995
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in PDF
  • 20% free customization (Pre-Sale)
  • Free quartery industry update
  • Free report update (Within 180 days)
  • Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo